Lumretuzumab
Monoclonal antibody | |
---|---|
Type | Whole antibody |
Source | Humanized (from mouse) |
Target | ERBB3 |
Clinical data | |
Synonyms | RG7116 |
ATC code |
|
Identifiers | |
CAS Number | |
ChemSpider |
|
UNII | |
Chemical and physical data | |
Formula | C6512H10064N1736O2052S44 |
Molar mass | 146.9 kDa |
Lumretuzumab (RG7116) (INN) is a humanized monoclonal antibody designed for the treatment of cancer.[1][2]
References
This article is issued from
Wikipedia.
The text is licensed under Creative Commons - Attribution - Sharealike.
Additional terms may apply for the media files.